![]()
|
|
||||||||
J. Biol. Chem., Vol. 265, Issue 27, 16311-16317, 09, 1990
H Lorberboum-Galski, RJ Garsia, M Gately, PS Brown, RE Clark, TA Waldmann, VK Chaudhary, DJ FitzGerald and I Pastan
To produce a molecule that will kill activated T cells as well as lymphomas
and leukemias expressing interleukin 2 (IL2) receptors, we have created a
recombinant chimeric protein in which IL2 is attached in peptide linkage to
a truncated mutant form of Pseudomonas exotoxin (PE) (Lorberboum-Galski,
H., FitzGerald, D.J.P., Chandhary, V.K., Adhya, S., and Pastan, I. (1988)
Proc. Natl. Acad. Sci. U.S.A. 85, 1922-1926). Although this molecule was
very active on rodent cells, it had lower activity on some human cell
types. A new chimeric protein termed IL2- PE664Glu has been constructed
that is extremely toxic to both phytohemagglutinin blasts and mixed
leukocyte reaction blasts prepared from monkey and human lymphocytes. The
chimeric gene encoding this protein was constructed by fusing a cDNA clone
for human interleukin 2 to the 5' end of a mutated cDNA encoding a
full-length PE molecule. Four amino acids in domain I of PE were changed
thus decreasing its nonspecific toxicity. IL2-PE664Glu is a much more
active cytotoxic molecule for primate and human-activated T cells than
IL2-PE40 which is a chimeric protein that was found to be an effective
immunosuppressive agent in rodent models. Our results indicate that
IL2-PE664Glu should be evaluated as an immunosuppressive agent for the
treatment of human immune disorders in which activated T cells expressing
the IL2 receptor are prominent.
IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes
Division of Cancer Biology and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Osusky, L. Teschke, X. Wang, K. Wong, and J. T. Buckley A Chimera of Interleukin 2 and a Binding Variant of Aerolysin Is Selectively Toxic to Cells Displaying the Interleukin 2 Receptor J. Biol. Chem., January 18, 2008; 283(3): 1572 - 1579. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nechushtan, S. Yarkoni, I. Marianovsky, and H. Lorberboum-Galski Adenocarcinoma Cells Are Targeted by the New GnRH-PE66 Chimeric Toxin through Specific Gonadotropin-releasing Hormone Binding Sites J. Biol. Chem., April 25, 1997; 272(17): 11597 - 11603. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mesri, M Ono, R. Kreitman, M Klagsbrun, and I Pastan The heparin-binding domain of heparin-binding EGF-like growth factor can target Pseudomonas exotoxin to kill cells exclusively through heparan sulfate proteoglycans J. Cell Sci., January 9, 1994; 107(9): 2599 - 2608. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |